Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT00181363

Completed

Prone Breast Irradiation for Pendulous Breasts

Breast Cancer
NCT02831439

Completed

A Statewide Intervention to Reduce Use of Unproven or Ineffective Breast Cancer Care

Breast Cancer
NCT01099436

Completed

Neo-Adjuvant Chemotherapy (TAC) With or Without Zoledronic Acid in Treating HER2-negative Breast Cancer Patients (NEO-ZOTAC)

Breast Cancer
NCT03611985

Withdrawn

Phase I/IIa Study of Pharmacokinetics and Safety of Epidiferphane™ and Taxanes in Breast Cancer Patients

Breast Cancer
NCT00140738

Completed

Safety and Immunogenicity Study of the New dHER2 Vaccine to Treat HER2-positive Metastatic Breast Cancer

Neoplasms, Breast
NCT01484483

Completed

An Observational Study to Register the Incidence of Breast Cancer and Current Clinical Care Patterns in Kenya

Breast Cancer
NCT04179318

Unknown

the New Geneswell BCT in Vitro Diagnosis of Breast Cancer Prognosis

Breast Cancer
NCT01263613

Completed

Feasibility Study of Biomarkers of Response to Neoadjuvant Paclitaxel in Locally Advanced Breast Cancer

Breast Cancer
NCT03210220

Completed

Efficacy of Preoperative Pectoral Nerve Block for Intraoperative Opioid Sparing Effect and Postoperative Analgesia

Breast Cancer
NCT00721409

Completed

Study Of Letrozole With Or Without Palbociclib (PD-0332991) For The First-Line Treatment Of Hormone-Receptor Positive Advanced Breast Cancer

Breast Cancer
NCT01104935

Completed

National Surgical Adjuvant Study of Breast Cancer(N-SAS BC) 07 [RESPECT] (RESPECT)

Breast Cancer
NCT01370239

Terminated

HumanaH - Hu3s193 in the Treatment of Advanced Breast Cancer After Hormonal Therapy

Breast Cancer
NCT00186121

Completed

Estradiol Suppression for the Treatment of Metastatic Breast Cancer in Premenopausal Women

Breast Cancer
NCT04109261

Completed

Analysis of Palbociclib Treatment in Patients With Advanced Breast Cancer Within a Compassionate Use Programe (PALBOCOMP)

Breast Cancer
NCT02582801

Terminated

Clinical Research of 18F-Alfatide Ⅱ PET/CT in Breast Cancer

Breast Cancer
NCT02954471

Completed

Study of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Participants With Early/Metastatic Breast Cancer in Saudi Arabia

Breast Cancer
NCT04093609

Unknown

XIST Gene Deletion in Breast Cancer Therapy

Breast Cancer
NCT03123263

Completed

Echocardiographic Changes During Adjuvant Therapy in Hispanic Women With Her-2 Neu Expressing Breast Cancer

Breast Cancer
NCT02056080

Completed

Clinical Benefit of the Treatment With Trastuzumab in Combination With Lapatinib in Metastatic Breast Cancer HER2 Positive Patients Who Has Been Previously Treated With Trastuzumab and/or Lapatinib (TRASTYVERE)

Breast Neoplasm
NCT02506777

Unknown

Neoadjuvant FDC With Melatonin or Metformin for Locally Advanced Breast Cancer. (MBC1)

Breast Cancer
NCT03472794

Completed

Adaptation of a Knowledges Exchange Portal Between (KEP) Healers and Patients : Obstacles and Sources to KEP Use for Breast Cancer Women (Sav-AQ)

Breast Cancer
NCT03779022

Unknown

miRNA and Relevant Biomarkers of BC Patients Undergoing Neoadjuvant Treatment

Breast Cancer
NCT02648802

Completed

Cavity Shaving in Breast Conserving Surgery for Breast Cancer Patients

Breast Cancer
NCT01234402

Completed

Study of Icrucumab (IMC-18F1) or Ramucirumab Drug Product (DP) in Combination With Capecitabine or Capecitabine on Previously Treated Breast Cancer Patients

Breast Cancer
NCT03575260

Completed

500mg Fulvestrant Versus Exemestane in MBC

Breast Cancer
NCT02619162

Completed

Nintedanib+Letrozole in Postmenopausal Women With Breast Cancer: Clinical Trial Safety and Pharmacodynamics

Breast Cancer
NCT03000920

Completed

Evaluation of the Short Message Service Effectiveness in the Screening Invitation Strategy for Breast Cancer (USIMaPI) (USIMaPI)

Breast Cancer
NCT04025112

Unknown

Randomized Clinical Trial Comparing Rehabilitation Robotic Versus Conventional After Breast Cancer Surgery

Breast Cancer
NCT02710058

Completed

Experience of Arab American Women With Breast Cancer: In-depth Interviews

Breast Cancer
NCT03582865

Unknown

Genetic Study of CYP2D6 Enzyme and Therapeutic Drug Monitoring of Tamoxifen

Breast Cancer
NCT02875626

Completed

Role of Indocyanine Green (ICG) for Detection of Sentinel Nodes in Breast Cancer

Breast Cancer
NCT03989258

Unknown

Personalised Risk-based Breast Cancer Prevention and Screening

Breast Cancer
NCT01183832

Completed

Radiotherapy - Anastrazole Concomitant : Evaluation of the Side Effects (ORACLES)

Breast Cancer
NCT00144898

Completed

GF-GS 01: Comparing Conventional Axillary Dissection Versus Sentinel Node Resection in Clinically Node-negative Operable Breast Cancer

Breast Cancer
NCT02311543

Completed

Impact of a Surgical Sealing Patch on Lymphatic Drainage After ALND for Breast Cancer

Breast Cancer
NCT02765373

Unknown

Effects of Adjuvant Endocrine Therapy With Aromatase Inhibitors on the Postoperative Lipid Levels in Postmenopausal Breast Cancer Patients

Breast Cancer
NCT03266562

Withdrawn

Estrogen Receptor Expression in Breast Cancer - Assessed With Positron Emission Mammography (PEM-FES)

Breast Neoplasm
NCT02777164

Terminated

Evaluation of a 3D Functional Metabolic Imaging and Risk Assessment System for Classifying Women at High Risk of Breast Cancer

Breast Cancer
NCT01929395

Completed

A Study to Evaluate the Use of Supine MRI Images in Breast Conserving Surgery

Breast Cancer
NCT00695968

Terminated

Breast Density and the Role of Preoperative Mammography, Ultrasound, Elastography and MRI

Breast Cancer
NCT01303419

Terminated

Contrast-Enhanced Digital Mammography (CEDM) for Identifying a Change in Management of Women With Newly Diagnosed Breast Cancer

Breast Cancer
NCT00462865

Terminated

Trial of Chemotherapy and Avastin as Treatment for Women With Breast Cancer at High Risk for Relapse

Breast Cancer
NCT02770781

Completed

Feasibility Study of the Addition of a Personal Trainer to the Post-Treatment Regimen of Breast Cancer Survivors

Breast Cancer
NCT00334542

Completed

Simvastatin in Preventing a New Breast Cancer in Women at High Risk for a New Breast Cancer

Breast Cancer
NCT03013881

Completed

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of UB-921 in Healthy Volunteers

Breast Neoplasm
NCT00908791

Completed

Proof of Principle Trial to Determine if Nutritional Supplement Conjugated Linoleic Acid (CLA) Can Modulate the Lipogenic Pathway in Breast Cancer Tissue

Breast Cancer
NCT03395327

Unknown

Pilot Study Describing the Early Evolution of the Sexual Function of Patients Receiving Adjuvant Hormone Therapy for Breast Cancer

Breast Cancer
NCT03888677

Completed

Dose-adjusted Adjuvant FEC Compared to Standard FEC for Breast Cancer

Breast Cancer
NCT00979641

Terminated

Biweekly Avastin and Docetaxel as the First Line Treatment for Patients With Metastatic Breast Cancer (AINO)

Neoplasms
NCT00709761

Completed

Phase II Lapatinib Plus Nab-Paclitaxel As First And Second Line Therapy In her2+ MBC

Neoplasms, Breast

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations